Ho and colleagues reported that treatment with a PTPN22 selective inhibitor, L-1, reduces the growth of MC38 and CT26 colon carcinomas in wild-type but not PTPN22-deficient mice [90]. The gene discussed is PTPN22; the disease is colon carcinoma.